Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lee, Terence K  [Clear All Filters]
2023
Yu H, Zhou L, Loong JHc, Lam K-H, Wong T-L, Ng K-Y, Tong M, Ma VWs, Wang Y, Zhang X, et al. SERPINA12 promotes the tumorigenic capacity of hepatocellular carcinoma stem cells through hyperactivation of AKT/ β-catenin signaling. Hepatology. 2023.
Man K-F, Zhou L, Yu H, Lam K-H, Cheng W, Yu J, Lee TK, Yun J-P, Guan X-Y, Liu M, et al. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma. Nat Commun. 2023;14(1):7863.
2022
Mok EH, Leung COi-Ning, Zhou L, Lei MMang Leng, Leung HWing, Tong M, Wong TLok, Lau EY, Ng IOi-Lin, Ding J, et al. Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma. Cancer Res. 2022.
2019
Luk ST, Ng K-Y, Zhou L, Tong M, Wong T-L, Yu H, Lo C-M, Man K, Guan X-Y, Lee TK, et al. Deficiency in embryonic stem cell marker REX1 activates MKK6-dependent p38 MAPK signaling to drive hepatocarcinogenesis. Hepatology. 2019.
2018
Chan LHei, Zhou L, Ng KYu, Wong TLok, Lee TK, Sharma R, Loong JH, Ching YPang, Yuan Y-F, Xie D, et al. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation. Cell Rep. 2018;25(3):690-701.e8.
2016
Chai S, Ng K-Y, Tong M, Lau EY, Lee TK, Chan KWah, Yuan Y-F, Cheung T-T, Cheung S-T, Wang X-Q, et al. Oct4/miR-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology. 2016.